Balance Sheet
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Gsk (GLAXF) Assets Average (2017 - 2025)

Gsk has reported Assets Average over the past 6 years, most recently at $314.1 billion for Q4 2025.

  • Quarterly results put Assets Average at $314.1 billion for Q4 2025, down 8.08% from a year ago — trailing twelve months through Dec 2025 was $314.1 billion (down 8.08% YoY), and the annual figure for FY2025 was $78.8 billion, up 5.39%.
  • Assets Average for Q4 2025 was $314.1 billion at Gsk, down from $341.7 billion in the prior quarter.
  • Over the last five years, Assets Average for GLAXF hit a ceiling of $371.2 billion in Q4 2023 and a floor of $314.1 billion in Q4 2025.
  • Median Assets Average over the past 4 years was $346.1 billion (2022), compared with a mean of $344.4 billion.
  • Biggest five-year swings in Assets Average: increased 5.89% in 2023 and later fell 8.08% in 2025.
  • Gsk's Assets Average stood at $350.6 billion in 2022, then grew by 5.89% to $371.2 billion in 2023, then fell by 7.96% to $341.7 billion in 2024, then fell by 8.08% to $314.1 billion in 2025.
  • The last three reported values for Assets Average were $314.1 billion (Q4 2025), $341.7 billion (Q4 2024), and $371.2 billion (Q4 2023) per Business Quant data.